News
Analysis
Podcasts
Learning
Community
Opens in new window
Jobs
Opens in new window
Awards News
Data
Opens in new window
Search
Search
News
Funding
Regulation
Business
Clinical
Product News
Politics
Locums
Independents
Multiples
Education
Coronavirus
Analysis
Explainers
Opinion
Salary Survey
Investigations
Crimes in pharmacies
Case Studies
Partnered Content
Podcasts
Learning
Community
Jobs
Find a job
Opens in new window
Post a job
Opens in new window
Awards News
Awards 2024
Opens in new window
Data
Login
Opens in new window
Data services
Opens in new window
Pharmacy subscriptions
More
About us
Advertise with us
Contact us
Help
Home
Methylphenidate: Are the tablets in yet?
22 May 2024
•
By
Malcolm Brown
Malcolm E. Brown discusses Methylphenidate shortages and the “medicalisation” of ADHD.
‘It costs nothing to be kind and empathetic’
Latest from Opinion
More from Analysis
